| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 341.68M | 369.10M | 426.78M | 511.94M | 571.41M |
| Gross Profit | 52.56M | 59.27M | 87.03M | 102.27M | 138.61M |
| EBITDA | -39.09M | -78.22M | -56.90M | 33.96M | 36.47M |
| Net Income | -51.12M | -76.93M | -60.61M | 18.16M | 20.20M |
Balance Sheet | |||||
| Total Assets | 300.08M | 366.74M | 478.29M | 573.84M | 454.17M |
| Cash, Cash Equivalents and Short-Term Investments | 70.60M | 65.78M | 92.52M | 118.20M | 90.84M |
| Total Debt | 730.31K | 994.00K | 20.57M | 35.94M | 3.99M |
| Total Liabilities | 293.68M | 281.02M | 305.37M | 336.33M | 249.12M |
| Stockholders Equity | -20.50M | 34.05M | 112.77M | 173.24M | 158.84M |
Cash Flow | |||||
| Free Cash Flow | 7.58M | 9.78M | 88.00K | 15.78M | -21.92M |
| Operating Cash Flow | 7.94M | 11.97M | 4.82M | 17.06M | -17.83M |
| Investing Cash Flow | 1.47M | -8.82M | -11.15M | -20.39M | -23.08M |
| Financing Cash Flow | -5.50M | -26.51M | -23.36M | 30.81M | -7.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$16.91B | 10.46 | 15.06% | 4.43% | 4.91% | 4.61% | |
71 Outperform | HK$14.48B | 15.06 | 11.18% | 2.78% | 6.95% | 28.21% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | HK$14.38B | 5.47 | 74.40% | ― | 6.46% | -3.32% | |
52 Neutral | HK$2.91B | 30.35 | 10.94% | ― | 7.77% | -7.65% | |
46 Neutral | HK$56.00M | -0.57 | -1110.70% | ― | -4.91% | 31.30% |